Dec 15 (Reuters) - The U.S. Food and Drug Administration said on Monday it has granted a national priority voucher to Johnson ...
Zacks Investment Research on MSN
CHMP backs higher-dose Wegovy as Novo Nordisk seeks 2026 EU approval
Novo Nordisk NVO announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) ...
Before Saturday’s snowstorm passed through the area, Seymour’s swim teams had already logged a productive day. Besides getting in pre- and post-meet workouts, the Owls dominated the six-team “S” Super ...
BlackRock Health Sciences Trust is a Buy for income investors, offering an 8% yield, NAV discount, and resilient healthcare ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the ...
Discover why Eli Lilly's stock downturn may present new opportunities. Learn about valuation, Zepbound pricing, and 2026 ...
President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...
No matter what happens to the industry, though, there are plenty of excellent healthcare stocks that look attractive heading ...
For 2026, the plan features significantly lower out-of-pocket costs for members who use the plan’s “narrow network” that ...
Construction is set to begin early next year on a $560 million project to send millions of gallons of water each day to ...
Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...
Eli Lilly will not seek a broad FDA approval for a combination of the company’s oral SERD med Inluriyo and CDK4/6 inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results